Glenohumeral Osteoarthritis
Musculoskeletal
Prevalence
8237.4 / 100K
Incidence
622.3 / 100K/yr
3 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| ZILRETTA | Pacira BioSciences, Inc. (PCRX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Glenohumeral Osteoarthritis?
BioSniper tracks 3 drugs in development for Glenohumeral Osteoarthritis across 2 companies.
How many clinical trials target Glenohumeral Osteoarthritis?
There are 1 clinical trial targeting Glenohumeral Osteoarthritis tracked by BioSniper.
What is the prevalence of Glenohumeral Osteoarthritis?
The estimated prevalence of Glenohumeral Osteoarthritis is approximately 8237.4 per 100,000 population.
Deep-dive into Glenohumeral Osteoarthritis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis